BMP-2 induction and TGF-β1 modulation of rat periosteal cell chondrogenesis

Keigo Hanada, Luis A. Solchaga, Arnold I. Caplan, Thomas M. Hering, Victor M. Goldberg, Jung Yoo, Brian Johnstone

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

Periosteum contains osteochondral progenitor cells that can differentiate into osteoblasts and chondrocytes during normal bone growth and fracture healing. TGF-β1 and BMP-2 have been implicated in the regulation of the chondrogenic differentiation of these cells, but their roles are not fully defined. This study was undertaken to investigate the chondrogenic effects of TGF-β1 and BMP-2 on rat periosteum-derived cells during in vitro chondrogenesis in a three-dimensional aggregate culture. RT-PCR analyses for gene expression of cartilage-specific matrix proteins revealed that treatment with BMP-2 alone and combined treatment with TGF-β1 and BMP-2 induced time-dependent mRNA expression of aggrecan core protein and type II collagen. At later times in culture, the aggregates treated with BMP-2 exhibited expression of type X collagen and osteocalcin mRNA, which are markers of chondrocyte hypertrophy. Aggregates incubated with both TGF-β1 and BMP-2 showed no such expression. Treatment with TGF-β1 alone did not lead to the expression of type II or X collagen mRNA, indicating that this factor itself did not independently induce chondrogenesis in rat periosteal cells. These data were consistent with histological and immunohistochemical results. After 14 days in culture, BMP-2-treated aggregates consisted of many hypertrophic chondrocytes within a metachromatic matrix, which was immunoreactive with anti-type II and type X collagen antibodies. In contrast, at 14 days, TGF-β1+BMP-2-treated aggregates did not contain any morphologically identifiable hypertrophic chondrocytes and their abundant extracellular matrix was not immunoreactive to the anti-type X collagen antibody. Expression of BMPR-IA, TGF-β RI, and TGF-β RII receptors was detected at all times in each culture condition, indicating that the distinct responses of aggregates to BMP-2, TGFβ1 and TGFβ1+BMP-2 were not due to overt differences in receptor expression. Collectively, our results suggest that BMP-2 induces neochondrogenesis of rat periosteum-derived cells, and that TGF-β1 modulates the terminal differentiation in BMP-2 induced chondrogenesis.

Original languageEnglish (US)
Pages (from-to)284-294
Number of pages11
JournalJournal of Cellular Biochemistry
Volume81
Issue number2
DOIs
StatePublished - 2001

Fingerprint

Collagen Type X
Chondrogenesis
Chondrocytes
Periosteum
Collagen Type II
Rats
Modulation
Messenger RNA
Matrilin Proteins
Aggrecans
Fracture Healing
Antibodies
Bone Development
Osteocalcin
Bone Fractures
Osteoblasts
Hypertrophy
Extracellular Matrix
Cell Differentiation
Stem Cells

Keywords

  • BMP-2
  • Chondrogenesis
  • Hypertrophy
  • Periosteum
  • TGF-β1

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Cite this

BMP-2 induction and TGF-β1 modulation of rat periosteal cell chondrogenesis. / Hanada, Keigo; Solchaga, Luis A.; Caplan, Arnold I.; Hering, Thomas M.; Goldberg, Victor M.; Yoo, Jung; Johnstone, Brian.

In: Journal of Cellular Biochemistry, Vol. 81, No. 2, 2001, p. 284-294.

Research output: Contribution to journalArticle

Hanada, Keigo ; Solchaga, Luis A. ; Caplan, Arnold I. ; Hering, Thomas M. ; Goldberg, Victor M. ; Yoo, Jung ; Johnstone, Brian. / BMP-2 induction and TGF-β1 modulation of rat periosteal cell chondrogenesis. In: Journal of Cellular Biochemistry. 2001 ; Vol. 81, No. 2. pp. 284-294.
@article{698c9143b6134b63b09d09fbe89ddf5d,
title = "BMP-2 induction and TGF-β1 modulation of rat periosteal cell chondrogenesis",
abstract = "Periosteum contains osteochondral progenitor cells that can differentiate into osteoblasts and chondrocytes during normal bone growth and fracture healing. TGF-β1 and BMP-2 have been implicated in the regulation of the chondrogenic differentiation of these cells, but their roles are not fully defined. This study was undertaken to investigate the chondrogenic effects of TGF-β1 and BMP-2 on rat periosteum-derived cells during in vitro chondrogenesis in a three-dimensional aggregate culture. RT-PCR analyses for gene expression of cartilage-specific matrix proteins revealed that treatment with BMP-2 alone and combined treatment with TGF-β1 and BMP-2 induced time-dependent mRNA expression of aggrecan core protein and type II collagen. At later times in culture, the aggregates treated with BMP-2 exhibited expression of type X collagen and osteocalcin mRNA, which are markers of chondrocyte hypertrophy. Aggregates incubated with both TGF-β1 and BMP-2 showed no such expression. Treatment with TGF-β1 alone did not lead to the expression of type II or X collagen mRNA, indicating that this factor itself did not independently induce chondrogenesis in rat periosteal cells. These data were consistent with histological and immunohistochemical results. After 14 days in culture, BMP-2-treated aggregates consisted of many hypertrophic chondrocytes within a metachromatic matrix, which was immunoreactive with anti-type II and type X collagen antibodies. In contrast, at 14 days, TGF-β1+BMP-2-treated aggregates did not contain any morphologically identifiable hypertrophic chondrocytes and their abundant extracellular matrix was not immunoreactive to the anti-type X collagen antibody. Expression of BMPR-IA, TGF-β RI, and TGF-β RII receptors was detected at all times in each culture condition, indicating that the distinct responses of aggregates to BMP-2, TGFβ1 and TGFβ1+BMP-2 were not due to overt differences in receptor expression. Collectively, our results suggest that BMP-2 induces neochondrogenesis of rat periosteum-derived cells, and that TGF-β1 modulates the terminal differentiation in BMP-2 induced chondrogenesis.",
keywords = "BMP-2, Chondrogenesis, Hypertrophy, Periosteum, TGF-β1",
author = "Keigo Hanada and Solchaga, {Luis A.} and Caplan, {Arnold I.} and Hering, {Thomas M.} and Goldberg, {Victor M.} and Jung Yoo and Brian Johnstone",
year = "2001",
doi = "10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D",
language = "English (US)",
volume = "81",
pages = "284--294",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - BMP-2 induction and TGF-β1 modulation of rat periosteal cell chondrogenesis

AU - Hanada, Keigo

AU - Solchaga, Luis A.

AU - Caplan, Arnold I.

AU - Hering, Thomas M.

AU - Goldberg, Victor M.

AU - Yoo, Jung

AU - Johnstone, Brian

PY - 2001

Y1 - 2001

N2 - Periosteum contains osteochondral progenitor cells that can differentiate into osteoblasts and chondrocytes during normal bone growth and fracture healing. TGF-β1 and BMP-2 have been implicated in the regulation of the chondrogenic differentiation of these cells, but their roles are not fully defined. This study was undertaken to investigate the chondrogenic effects of TGF-β1 and BMP-2 on rat periosteum-derived cells during in vitro chondrogenesis in a three-dimensional aggregate culture. RT-PCR analyses for gene expression of cartilage-specific matrix proteins revealed that treatment with BMP-2 alone and combined treatment with TGF-β1 and BMP-2 induced time-dependent mRNA expression of aggrecan core protein and type II collagen. At later times in culture, the aggregates treated with BMP-2 exhibited expression of type X collagen and osteocalcin mRNA, which are markers of chondrocyte hypertrophy. Aggregates incubated with both TGF-β1 and BMP-2 showed no such expression. Treatment with TGF-β1 alone did not lead to the expression of type II or X collagen mRNA, indicating that this factor itself did not independently induce chondrogenesis in rat periosteal cells. These data were consistent with histological and immunohistochemical results. After 14 days in culture, BMP-2-treated aggregates consisted of many hypertrophic chondrocytes within a metachromatic matrix, which was immunoreactive with anti-type II and type X collagen antibodies. In contrast, at 14 days, TGF-β1+BMP-2-treated aggregates did not contain any morphologically identifiable hypertrophic chondrocytes and their abundant extracellular matrix was not immunoreactive to the anti-type X collagen antibody. Expression of BMPR-IA, TGF-β RI, and TGF-β RII receptors was detected at all times in each culture condition, indicating that the distinct responses of aggregates to BMP-2, TGFβ1 and TGFβ1+BMP-2 were not due to overt differences in receptor expression. Collectively, our results suggest that BMP-2 induces neochondrogenesis of rat periosteum-derived cells, and that TGF-β1 modulates the terminal differentiation in BMP-2 induced chondrogenesis.

AB - Periosteum contains osteochondral progenitor cells that can differentiate into osteoblasts and chondrocytes during normal bone growth and fracture healing. TGF-β1 and BMP-2 have been implicated in the regulation of the chondrogenic differentiation of these cells, but their roles are not fully defined. This study was undertaken to investigate the chondrogenic effects of TGF-β1 and BMP-2 on rat periosteum-derived cells during in vitro chondrogenesis in a three-dimensional aggregate culture. RT-PCR analyses for gene expression of cartilage-specific matrix proteins revealed that treatment with BMP-2 alone and combined treatment with TGF-β1 and BMP-2 induced time-dependent mRNA expression of aggrecan core protein and type II collagen. At later times in culture, the aggregates treated with BMP-2 exhibited expression of type X collagen and osteocalcin mRNA, which are markers of chondrocyte hypertrophy. Aggregates incubated with both TGF-β1 and BMP-2 showed no such expression. Treatment with TGF-β1 alone did not lead to the expression of type II or X collagen mRNA, indicating that this factor itself did not independently induce chondrogenesis in rat periosteal cells. These data were consistent with histological and immunohistochemical results. After 14 days in culture, BMP-2-treated aggregates consisted of many hypertrophic chondrocytes within a metachromatic matrix, which was immunoreactive with anti-type II and type X collagen antibodies. In contrast, at 14 days, TGF-β1+BMP-2-treated aggregates did not contain any morphologically identifiable hypertrophic chondrocytes and their abundant extracellular matrix was not immunoreactive to the anti-type X collagen antibody. Expression of BMPR-IA, TGF-β RI, and TGF-β RII receptors was detected at all times in each culture condition, indicating that the distinct responses of aggregates to BMP-2, TGFβ1 and TGFβ1+BMP-2 were not due to overt differences in receptor expression. Collectively, our results suggest that BMP-2 induces neochondrogenesis of rat periosteum-derived cells, and that TGF-β1 modulates the terminal differentiation in BMP-2 induced chondrogenesis.

KW - BMP-2

KW - Chondrogenesis

KW - Hypertrophy

KW - Periosteum

KW - TGF-β1

UR - http://www.scopus.com/inward/record.url?scp=0035047961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035047961&partnerID=8YFLogxK

U2 - 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D

DO - 10.1002/1097-4644(20010501)81:2<284::AID-JCB1043>3.0.CO;2-D

M3 - Article

VL - 81

SP - 284

EP - 294

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 2

ER -